Switzer.com.auSwitzer ReportSwitzer AdvisoryReport a Problem
SwitzerReport

Independent. Trusted. Proven.

Articles

Expert buy, hold and sell recommendations from our team of analysts.

Questions of the Week — Q&A
Premium
Featured

Questions of the Week

Is the US market now underperforming the rest of the world? Should I be looking at ETFs other than IHVV? If Stokes and his partner are now offering $32.75 for BlueScope, why are the shares trading under $30? How did the brokers react to BHP’s profit report? Is there a single source where dividend amounts, dates and franking advice is easily available?

Paul Rickard · February 19, 2026
Are these stocks the buys of the century? — Shares
Premium
Shares

Are these stocks the buys of the century?

Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing a hijacking of great businesses by market 'terrorists' that we could make money out of?

Peter Switzer · February 16, 2026
3 potential medical device stars — Shares
Premium
Shares

3 potential medical device stars

Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.

James Dunn · February 16, 2026
“HOT” stock: Orica (ORI) — Shares
Premium
Shares

“HOT” stock: Orica (ORI)

In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains in more detail why he believes that ORI is just undergoing a healthy consolidation and is ready to move higher again.

Maureen Jordan · February 12, 2026

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.